GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of tried EU for 16 weeks. here is what happened. — 25 comments in the full submission. View in context.
618
c/glp1eu·submitted 2 months ago by u/solene_ilunga

tried EU for 16 weeks. here is what happened.

Questionbranch of 6 comments

Posting this because I searched for it and got nothing useful. Setup: 0.5mg, week 95, constipation present but not ruining anything. I changed exactly one variable — reimbursement — and tracked it for 3 weeks. Result: a difference, but a small one, and well inside what I would call noise if someone else posted it. So…

Read the full submission and all 25 comments →

This branch

6 comments, started 2 months ago
u/ignacio_silva12 points·2 months ago

private and public prescription routes differ

replysharereportpermalink
u/cormac_erdogan6 points·2 months ago

This is the "correlation is mechanism" thing again. You changed three variables at once.

replysharereportpermalink
u/ignacio_silva3 points·2 months ago

pricing posts need date and currency

replysharereportpermalink
u/camila_marchand2 points·2 months ago

apotheke, receta, pharmacy — twenty-seven different answers

replysharereportpermalink
u/nadia_nascimento3 points·2 months ago

reimbursement reality differs sharply

replysharereportpermalink
u/lucia_bruun4 points·2 months ago·edited

EMA notices are different from national ones

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.